Phase I Study of Ruxolitinib in Combination with Abemaciclib for Patients with Primary or Post-Polycythemia Vera/ Essential Thrombocythemia Myelofibrosis

被引：0

作者：

Bewersdorf, Jan Philipp ^{[1
]}

Verstovsek, Srdan ^{[2
]}

Derkach, Andriy ^{[3
]}

Masarova, Lucia ^{[4
]}

Pemmaraju, Naveen ^{[4
]}

Stein, Eytan ^{[5
]}

Mauro, Michael ^{[5
]}

Rampal, Raajit K. ^{[5
]}

Bose, Prithviraj ^{[4
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med Leukemia Serv, New York, NY 10021 USA

[2] Univ Texas MD Anderson Canc Ctr, Leukemia Dept, Houston, TX 77030 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, New York, NY USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA

来源：

关键词：

D O I：

10.1182/blood-2022-158678

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：6844 / 6846

页数：3